US 8809310
Use of rasagiline for the treatment of multiple system atrophy
granted A61KA61K31/13A61K31/135
Quick answer
US patent 8809310 (Use of rasagiline for the treatment of multiple system atrophy) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/13, A61K31/135, A61K31/191, A61K31/195